Selank
A synthetic peptide derived from tuftsin, developed in Russia and studied for anxiolytic and cognitive effects without sedation.
Research status: Human studies from Russian research groups; limited independent Western trials.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
Selected references
- Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · 2008 Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia
- Behavioural Neurology · 2017 Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats
- Frontiers in Pharmacology · 2016 Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
- Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · 2014 A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders
Curated from published literature for research orientation. Not an exhaustive review, and not a substitute for reading primary sources.
Related in Cognitive